Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic LeukemiaTait D. Shanafelt, Martin S. Tallman, Diane F. Jelinek et al.|New England Journal of Medicine|2019Cited by 735
Mutations and thrombosis in essential thrombocythemiaPaola Guglielmelli, Ayalew Tefferi, Naseema Gangat et al.|Blood Cancer Journal|2021Cited by 41
Young platelet millionaires with essential thrombocythemiaNaseema Gangat, Ayalew Tefferi, Animesh Pardanani et al.|American Journal of Hematology|2021Cited by 21